SpineGuard Past Earnings Performance

Past criteria checks 0/6

SpineGuard's earnings have been declining at an average annual rate of -22.3%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been declining at an average rate of 7.9% per year.

Key information

-22.3%

Earnings growth rate

14.2%

EPS growth rate

Medical Equipment Industry Growth21.6%
Revenue growth rate-7.9%
Return on equity-86.5%
Net Margin-83.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Would SpineGuard (EPA:ALSGD) Be Better Off With Less Debt?

Sep 30
Would SpineGuard (EPA:ALSGD) Be Better Off With Less Debt?

Does SpineGuard (EPA:ALSGD) Have A Healthy Balance Sheet?

Sep 30
Does SpineGuard (EPA:ALSGD) Have A Healthy Balance Sheet?

Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

Sep 26
Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

Is SpineGuard (EPA:ALSGD) A Risky Investment?

May 10
Is SpineGuard (EPA:ALSGD) A Risky Investment?

Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

Nov 22
Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

Revenue & Expenses Breakdown

How SpineGuard makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALSGD Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 245-462
31 Mar 244-462
31 Dec 234-461
30 Sep 235-461
30 Jun 235-361
31 Mar 235-361
31 Dec 226-251
30 Sep 225-251
30 Jun 225-251
31 Mar 225-241
31 Dec 214-241
30 Sep 215-241
30 Jun 215-241
31 Mar 215-241
31 Dec 205-341
30 Sep 205-241
30 Jun 206-151
31 Mar 206-151
31 Dec 197-151
30 Sep 197-161
30 Jun 197-261
31 Mar 197-261
31 Dec 188-271
30 Sep 188-371
30 Jun 188-371
31 Mar 188-481
31 Dec 178-481
30 Sep 178-481
30 Jun 178-491
31 Mar 178-491
31 Dec 167-491
30 Sep 167-491
30 Jun 167-491
31 Mar 167-491
31 Dec 156-481
30 Sep 156-481
30 Jun 155-481
31 Mar 155-481
31 Dec 144-571
30 Sep 144-471
30 Jun 144-471
31 Mar 145-471
31 Dec 135-461

Quality Earnings: ALSGD is currently unprofitable.

Growing Profit Margin: ALSGD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALSGD is unprofitable, and losses have increased over the past 5 years at a rate of 22.3% per year.

Accelerating Growth: Unable to compare ALSGD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALSGD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.5%).


Return on Equity

High ROE: ALSGD has a negative Return on Equity (-86.5%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 10:17
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SpineGuard SA is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martial DescouturesInvest Securities
Maja PatakiKepler Cheuvreux
Lionel LabourdetteKepler Cheuvreux